Contrast Media Market Size, Share, Growth Analysis, By Type(Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media, Barium-based Contrast Media), By Form(Liquid Contrast Media, Powder Contrast Media, Other Forms), By Modality(X-RAY, CT, MRI, Ultrasound), By Route of Administration(Intravascular Route [Intravenous (IV) route, Intra-arterial (IA) route], Oral Route, Rectal Route), By Indication(Cardiovascular Disease, Cancer, Gastrointestinal Disorders, Musculoskeletal Disorders), By Application(Radiology, Interventional Radiology, Interventional Cardiology), By End User(Hospitals, Clinics, And Ambulatory Surgery Centers, Diagnostic Imaging Centers), By Region - Industry Forecast 2024-2031

North America held the largest share of the global contrast media market in 2021. It was roughly 44.44%. This is expected to change as a result of numerous strategic initiatives done by important manufacturers to target certain patient subgroups in this area. GE Healthcare, Guerbet, Lantheus, and Bracco Diagnostics are some of the major market participants.

The existence of well-established healthcare facilities, easy access to cutting-edge technology, and a strong demand for diagnostic procedures due to illness screening programs and disease management in this region are all projected to lead to an increase in inpatient exams. The number of operations could be reduced, nevertheless, as a result of healthcare reforms that impose standards for proper usage and limit needless ones.

Additionally, Asia Pacific had a substantial market share in 2021. This can be due to the region's established local and international manufacturers. For instance, one of the major contrast media manufacturing facilities of GE Healthcare is General Electric Pharmaceuticals (Shanghai) Co., Ltd., a division of GE that manufactures diagnostic pharmaceuticals (CT/MR contrast media) in China. It is projected that this element would continue to fuel regional market expansion.